Add to ORKG[[sponsorship]]化學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1535-3893&DestApp=JCR&RQ=IF_CAT_BOXPLO
Importance: There is an urgent need to improve lung cancer risk assessment because current screening...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...
Alice Mogenet, Laurent Greillier, Pascale Tomasini Aix Marseille University, CNRS, INSERM, CRCM, APH...
Lung cancer is the leading cause of cancer mortality worldwide. Although many biomarkers have been i...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
科学研究費補助金研究成果報告書研究種目: 研究活動スタート支援研究期間: 2010～2011課題番号: 22890085研究代表者: 高野 淳（滋賀医科大学・医学部・特任助教）連携研究者: 醍醐 弥太...
Non-small-cell lung cancer (NSCLC) constitutes approximately 80% of all diagnosed lung cancers, and ...
Background: A panel of 3 serum proteins and 1 autoantibody has been developed to assist with the det...
AbstractCurrently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 ...
Background\ud CT screening for lung cancer is effective in reducing mortality, but there are areas o...
Currently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 lung can...
Introduction:Lung cancer remains the leading cause of cancer-related death with poor survival due to...
textabstractLung cancer is currently one of the most common types of cancer with the highest mortali...
[[sponsorship]]統計科學研究所[[note]]出版中(submitted);[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
PurposeThere is a critical need for improvements in the noninvasive diagnosis of lung cancer. We hyp...
Importance: There is an urgent need to improve lung cancer risk assessment because current screening...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...
Alice Mogenet, Laurent Greillier, Pascale Tomasini Aix Marseille University, CNRS, INSERM, CRCM, APH...
Lung cancer is the leading cause of cancer mortality worldwide. Although many biomarkers have been i...
[[sponsorship]]統計科學研究所[[note]]已出版;[SCI];有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
科学研究費補助金研究成果報告書研究種目: 研究活動スタート支援研究期間: 2010～2011課題番号: 22890085研究代表者: 高野 淳（滋賀医科大学・医学部・特任助教）連携研究者: 醍醐 弥太...
Non-small-cell lung cancer (NSCLC) constitutes approximately 80% of all diagnosed lung cancers, and ...
Background: A panel of 3 serum proteins and 1 autoantibody has been developed to assist with the det...
AbstractCurrently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 ...
Background\ud CT screening for lung cancer is effective in reducing mortality, but there are areas o...
Currently, there is no available biomarker for lung cancer diagnosis. Here we recruited 844 lung can...
Introduction:Lung cancer remains the leading cause of cancer-related death with poor survival due to...
textabstractLung cancer is currently one of the most common types of cancer with the highest mortali...
[[sponsorship]]統計科學研究所[[note]]出版中(submitted);[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
PurposeThere is a critical need for improvements in the noninvasive diagnosis of lung cancer. We hyp...
Importance: There is an urgent need to improve lung cancer risk assessment because current screening...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...
Alice Mogenet, Laurent Greillier, Pascale Tomasini Aix Marseille University, CNRS, INSERM, CRCM, APH...